Assessment and Comparison of Efficacy of Intra-Articular PRP and Corticosteroid in First CMC Joint OA Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

July 30, 2022

Study Completion Date

July 30, 2022

Conditions
Thumb OsteoarthritisHand OsteoarthritisPlatelet Rich PlasmaCorticosteroidIntra-articular InjectionUltrasonography
Interventions
DRUG

PRP

A single dose of 1 ml PRP (Vacusera) was injected into the 1st CMC joint of the first group. Injection was performed under USG (Clarius; L7 HD Linear Ultrasound Scanner) guidance by the same physician after skin sterilization.

DRUG

Corticosteroid

A single dose of 20 mg(1ml) of methyl-prednisolone (Depo-Medrol) (complemented to 1 ml by adding 0.5 ml of saline) was injected to the 1st CMC joint of the second group. Injection was performed under USG (Clarius; L7 HD Linear Ultrasound Scanner) guidance by the same physician after skin sterilization.

Trial Locations (1)

55400

Antalya Training and Research Hospital, Antalya

All Listed Sponsors
lead

Antalya Training and Research Hospital

OTHER_GOV